| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6c17612db7d98bb4baf5d622f5250492 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2013
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-155 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-155 |
| filingDate |
1999-06-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_471316fc29f5465d170261dbda15699a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2418dae6ad8454540a086d2817b392c3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f4f830f9284ed39306f06453482826c4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dcd4eafef03e353d175e2bf8ff087b97 |
| publicationDate |
1999-09-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
FR-2776189-A1 |
| titleOfInvention |
METFORMIN-BASED GALENIC FORM WITH IMMEDIATE RELEASE OR PROLONGED RELEASE ADMINISTRATED ORALLY INCLUDING AN ABSORPTION PROMOTING AGENT AND USE OF THIS ABSORPTION PROMOTING AGENT |
| abstract |
The present invention relates to a galenic form which can be administered orally allowing improved absorption via the transmembrane or paracellular route in the gastrointestinal tract of an active principle chosen from metformin and one of its pharmaceutically acceptable salts, comprising at least one such principle. active agent, and at least one polyglycolyzed glyceride as absorption promoter in combination with one or more pharmaceutically acceptable excipients, said polyglycolyzed glyceride having an HLB greater than 8. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7892582-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004064542-A1 |
| priorityDate |
1999-06-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |